Blog

May 5, 2017

CBD and schizophrenia: therapeutic prospects.

Summary: Approximately one third of patients diagnosed with schizophrenia do not achieve adequate symptom control with standard antipsychotic drugs (APs). Some of these may prove responsive […]
May 5, 2017

CBD as a potential treatment for psychosis.

Summary: Although cannabis use is associated with an increased risk of developing psychosis, the cannabis constituent cannabidiol (CBD) may have antipsychotic properties. This review concisely describes […]
May 5, 2017

CBD, a Cannabis sativa constituent, as an antipsychotic drug.

Summary: A high dose of delta9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of delta9-tetrahydrocannabinol are significantly […]
May 5, 2017

Effects of acute systemic administration of CBD on sleep-wake cycle in rats.

Summary: Cannabidiol (CBD) is one of the main components of Cannabis sativa and has a wide spectrum of action, including effects in the sleep-wake cycle. OBJECTIVE: […]
May 5, 2017

CBD exerts sebostatic and antiinflammatory effects on human sebocytes.

Summary: The endocannabinoid system (ECS) regulates multiple physiological processes, including cutaneous cell growth and differentiation. Here, we explored the effects of the major nonpsychotropic phytocannabinoid of […]
May 5, 2017

CBD regulation of emotion and emotional memory processing

Summary: Learning to associate cues or contexts with potential threats or rewards is adaptive and enhances survival. Both aversive and appetitive memories are therefore powerful drivers […]
May 5, 2017

Effects of CBD on regional cerebral blood flow.

Summary: Animal and human studies have suggested that cannabidiol (CBD) may possess anxiolytic properties, but how these effects are mediated centrally is unknown. The aim of […]
May 5, 2017

CBD reduces the anxiety induced by simulated public speaking in treatment

Summary: Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions with impairment in social life. Cannabidiol (CBD), one major non-psychotomimetic compound of […]